Global diagnosed HIV prevalence to reach over 2.2 mn in 2033: Report

0
18
Global diagnosed HIV prevalence to reach over 2.2 mn in 2033: Report
Advetisment

New Delhi, Jan 10 (IANS) The diagnosed prevalent cases of human immunodeficiency virus (HIV) are projected to increase globally at an annual growth rate (AGR) of 0.90 per cent from 2.00 million in 2023 to 2.18 million in 2033, according to a report on Friday.

The report by GlobalData, a leading data and analytics company, showed that this rise in HIV cases will majorly be seen in the US, France, Germany, Italy, Spain, the UK, and Japan.

It estimates that in 2033, the US will have the highest number of diagnosed prevalent cases of HIV in these seven countries, with approximately 1.46 million cases.

On the other hand, Japan will have the fewest diagnosed prevalent cases with approximately 34,400 cases.

“Diagnosed prevalent cases of HIV are expected to increase due to a combination of the increased diagnosis rate of HIV, the increased life expectancy of HIV-positive people due to anti-retroviral treatment (ART), and population dynamics in these countries,” said Casey Freimuth, Senior Epidemiologist at GlobalData.

There are tools available to reduce future HIV prevalence, such as viral suppression through ART, pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP).

PrEP is only recently approved in the US and the five European nations such as France, Germany, Italy, Spain, and the UK. It is not yet accepted in Japan.

“Future efforts to reduce the burden of HIV should involve increased attention on reducing transmission, either through PrEP or through the use of ART, in combination with education and increased access to testing,” Freimuth said.

Meanwhile, the recent approval of lenacapavir by the US Federal Drug Administration (FDA) has come as a significant breakthrough in treating HIV. The new prototype medication, developed by Gilead Sciences, uses a unique mechanism of twice-yearly injections to treat individuals with multidrug-resistant HIV.

–IANS

rvt/

Go to Source

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

Advertisment